Simulations Plus (NASDAQ:SLP) Issues Earnings Results, Beats Estimates By $0.01 EPS

Share on StockTwits

Simulations Plus (NASDAQ:SLP) posted its earnings results on Sunday. The technology company reported $0.12 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.11 by $0.01, MarketWatch Earnings reports. Simulations Plus had a net margin of 22.96% and a return on equity of 24.44%.

NASDAQ SLP opened at $79.33 on Tuesday. The company has a fifty day moving average price of $65.06 and a 200-day moving average price of $65.43. The firm has a market cap of $1.58 billion, a price-to-earnings ratio of 158.66, a PEG ratio of 7.63 and a beta of -0.17. Simulations Plus has a 1 year low of $26.00 and a 1 year high of $83.78.

SLP has been the topic of a number of recent analyst reports. Raymond James started coverage on shares of Simulations Plus in a research report on Friday, October 16th. They issued an “outperform” rating and a $95.00 price target on the stock. Taglich Brothers upgraded Simulations Plus from a “speculative buy” rating to a “buy” rating and set a $76.00 target price for the company in a report on Wednesday, November 25th. Zacks Investment Research downgraded shares of Simulations Plus from a “hold” rating to a “sell” rating in a research report on Thursday, November 19th. BidaskClub raised Simulations Plus from a “hold” rating to a “buy” rating in a research report on Wednesday, December 23rd. Finally, TheStreet raised shares of Simulations Plus from a “c+” rating to a “b” rating in a research note on Friday. One research analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the stock. Simulations Plus presently has a consensus rating of “Buy” and a consensus target price of $80.40.

In other news, CEO Shawn Oconnor sold 6,381 shares of the firm’s stock in a transaction on Monday, November 30th. The stock was sold at an average price of $56.50, for a total transaction of $360,526.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Walter S. Woltosz sold 24,000 shares of Simulations Plus stock in a transaction on Wednesday, December 23rd. The stock was sold at an average price of $72.71, for a total value of $1,745,040.00. Following the sale, the director now owns 4,659,614 shares in the company, valued at $338,800,533.94. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 64,881 shares of company stock worth $4,347,992. 31.57% of the stock is owned by corporate insiders.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments; and MembranePlus, which simulates laboratory experiments.

Featured Story: Analyzing a company’s cash flow statement

Earnings History for Simulations Plus (NASDAQ:SLP)

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with's FREE daily email newsletter.